Stromal matrix metalloprotease-13 knockout alters Collagen I structure at the tumor-host interface and increases lung metastasis of C57BL/6 syngeneic E0771 mammary tumor cells

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Perry, Seth W ^a   Schueckler, Jill M ^a   Burke, Kathleen ^a   Arcuri, Giuseppe L ^a   Brown, Edward B ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Cancer; Collagen; Fluorophore; Imaging; In vivo; Intravital; Intrinsic; Matrix metalloprotease; Microscopy; MMP; MMP 13; Multiphoton; Second harmonic generation; SHG; Tumor; Two photon

Indexed keywords

COLLAGEN TYPE 1; COLLAGENASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; C57BL/6N MOUSE; CONTROLLED STUDY; GENETIC MANIPULATION; IMMUNOCYTOCHEMISTRY; LUNG METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PROTEIN STRUCTURE; TUMOR MICROENVIRONMENT;

ANIMALS; CELL LINE, TUMOR; COLLAGEN TYPE I; FEMALE; HUMANS; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASE 13; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TRANSPLANTATION, ISOGENEIC; TUMOR BURDEN;

EID: 84883445434     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-411     Document Type: Article

References (71)

1. Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 2012, 196(4):395-406. 10.1083/jcb.201102147, 3283993, 22351925.
2. Spano D, Zollo M. Tumor microenvironment: a main actor in the metastasis process. Clin Exp Metastasis 2012, 29(4):381-395. 10.1007/s10585-012-9457-5, 22322279.
3. Wolf K, Alexander S, Schacht V, Coussens LM, von Andrian UH, van Rheenen J, Deryugina E, Friedl P. Collagen-based cell migration models in vitro and in vivo. Semin Cell Dev Biol 2009, 20(8):931-941. 10.1016/j.semcdb.2009.08.005, 19682592.
4. Han X, Burke RM, Zettel ML, Tang P, Brown EB. Second harmonic properties of tumor collagen: determining the structural relationship between reactive stroma and healthy stroma. Opt Express 2008, 16(3):1846-1859. 10.1364/OE.16.001846, 18542263.
5. Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med 2006, 4(1):38. 10.1186/1741-7015-4-38, 1781458, 17190588.
6. Hompland T, Erikson A, Lindgren M, Lindmo T, de Lange Davies C. Second-harmonic generation in collagen as a potential cancer diagnostic parameter. J Biomed Opt 2008, 13(5):054050. 10.1117/1.2983664, 19021430.
7. Brown E, McKee T, DiTomaso E, Pluen A, Seed B, Boucher Y, Jain RK. Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation. Nat Med 2003, 9(6):796-800. 10.1038/nm879, 12754503.
8. Schedin P, Keely PJ. Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. Cold Spring Harb Perspect Biol 2011, 3(1):a003228. 10.1101/cshperspect.a003228, 3003460, 20980442.
9. Perry SW, Burke RM, Brown EB. Two-photon and second harmonic microscopy in clinical and translational cancer research. Ann Biomed Eng 2012, 40(2):277-291. 10.1007/s10439-012-0512-9, 3342697, 22258888.
10. Provenzano PP, Inman DR, Eliceiri KW, Trier SM, Keely PJ. Contact guidance mediated three-dimensional cell migration is regulated by Rho/ROCK-dependent matrix reorganization. Biophys J 2008, 95(11):5374-5384. 10.1529/biophysj.108.133116, 2586586, 18775961.
11. Wang W, Wyckoff JB, Goswami S, Wang Y, Sidani M, Segall JE, Condeelis JS. Coordinated regulation of pathways for enhanced cell motility and chemotaxis is conserved in rat and mouse mammary tumors. Cancer Res 2007, 67(8):3505-3511. 10.1158/0008-5472.CAN-06-3714, 17440055.
12. Conklin MW, Eickhoff JC, Riching KM, Pehlke CA, Eliceiri KW, Provenzano PP, Friedl A, Keely PJ. Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am J Pathol 2011, 178(3):1221-1232. 10.1016/j.ajpath.2010.11.076, 3070581, 21356373.
13. Binder C, Hagemann T, Husen B, Schulz M, Einspanier A. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases. Mol Hum Reprod 2002, 8(9):789-796. 10.1093/molehr/8.9.789, 12200455.
14. Binder C, Simon A, Binder L, Hagemann T, Schulz M, Emons G, Trumper L, Einspanier A. Elevated concentrations of serum relaxin are associated with metastatic disease in breast cancer patients. Breast Cancer Res Treat 2004, 87(2):157-166. 10.1023/B:BREA.0000041622.30169.16, 15377840.
15. Ala-aho R, Kahari VM. Collagenases in cancer. Biochimie 2005, 87(3-4):273-286.
16. Freije JM, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, Lopez-Otin C. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994, 269(24):16766-16773.
17. Balbin M, Pendas AM, Uria JA, Jimenez MG, Freije JP, Lopez-Otin C. Expression and regulation of collagenase-3 (MMP-13) in human malignant tumors. APMIS 1999, 107(1):45-53.
18. Zhang B, Cao X, Liu Y, Cao W, Zhang F, Zhang S, Li H, Ning L, Fu L, Niu Y, et al. Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer. BMC Cancer 2008, 8:83. 10.1186/1471-2407-8-83, 2362123, 18373849.
19. Provenzano PP, Inman DR, Eliceiri KW, Knittel JG, Yan L, Rueden CT, White JG, Keely PJ. Collagen density promotes mammary tumor initiation and progression. BMC Med 2008, 6:11. 10.1186/1741-7015-6-11, 2386807, 18442412.
20. Gelse K, Poschl E, Aigner T. Collagens-structure, function, and biosynthesis. Adv Drug Deliv Rev 2003, 55(12):1531-1546. 10.1016/j.addr.2003.08.002, 14623400.
21. Rudnick JA, Kuperwasser C. Stromal biomarkers in breast cancer development and progression. Clin Exp Metastasis 2012, 29(7):633-672.
22. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986, 315(26):1650-1659. 10.1056/NEJM198612253152606, 3537791.
23. Inada M, Wang Y, Byrne MH, Rahman MU, Miyaura C, Lopez-Otin C, Krane SM. Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc Natl Acad Sci USA 2004, 101(49):17192-17197. 10.1073/pnas.0407788101, 535367, 15563592.
24. Rezakhaniha R, Agianniotis A, Schrauwen JT, Griffa A, Sage D, Bouten CV, van de Vosse FN, Unser M, Stergiopulos N. Experimental investigation of collagen waviness and orientation in the arterial adventitia using confocal laser scanning microscopy. Biomech Model Mechanobiol 2012, 11(3-4):461-473.
25. Bigun J, Bigun T, Nilsson K. Recognition by symmetry derivatives and the generalized structure tensor. IEEE Trans Pattern Anal Mach Intell 2004, 26(12):1590-1605. 10.1109/TPAMI.2004.126, 15573820.
26. Haußecker H, Jähne B. A Tensor Approach for Local Structure Analysis in Multi-Dimensional Images. Proceedings 3D Image Analysis and Synthesis '96 Proceedings in Artifical Intelligence 1996, 171-178. Erlangen, Germany, Sankt Augustin: Infix (now Aka/IOS Press), Girod B, Niemann H, Seidel H-P.
27. Perry SW, Han X, Brown EB. Second Harmonic Generation in Tumors: Scattering and Polarization. Second Harmonic Generation Imaging. Volume In Press 2012, London, UK: Taylor and Francis, Pavone FS, Campagnola PJ.
28. Diop-Frimpong B, Chauhan VP, Krane S, Boucher Y, Jain RK. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors. Proc Natl Acad Sci USA 2011, 108(7):2909-2914. 10.1073/pnas.1018892108, 3041115, 21282607.
29. Ingman WV, Wyckoff J, Gouon-Evans V, Condeelis J, Pollard JW. Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland. Dev Dyn 2006, 235(12):3222-3229. 10.1002/dvdy.20972, 17029292.
30. Burke K, Tang P, Brown E. Second harmonic generation reveals matrix alterations during breast tumor progression. J Biomed Opt 2013, 18(3):31106.
31. Nielsen BS, Egeblad M, Rank F, Askautrud HA, Pennington CJ, Pedersen TX, Christensen IJ, Edwards DR, Werb Z, Lund LR. Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression. PloS ONE 2008, 3(8):e2959. 10.1371/journal.pone.0002959, 2493034, 18698413.
32. Mohler W, Millard AC, Campagnola PJ. Second harmonic generation imaging of endogenous structural proteins. Methods 2003, 29(1):97-109. 10.1016/S1046-2023(02)00292-X, 12543075.
33. Campagnola PJ, Loew LM. Second-harmonic imaging microscopy for visualizing biomolecular arrays in cells, tissues and organisms. Nat Biotechnol 2003, 21(11):1356-1360. 10.1038/nbt894, 14595363.
34. Mertz J, Moreaux L. Second harmonic generation by focused excitation of inhomogeneously distributed scatterers. Opt Commun 2001, 196(1-6):325-330.
35. Pantazis P, Maloney J, Wu D, Fraser SE. Second harmonic generating (SHG) nanoprobes for in vivo imaging. Proc Natl Acad Sci USA 2010, 107(33):14535-14540. 10.1073/pnas.1004748107, 2930484, 20668245.
36. Reeve JE, Anderson HL, Clays K. Dyes for biological second harmonic generation imaging. Phys Chem Chem Phys 2010, 12(41):13484-13498. 10.1039/c003720f, 20820473.
37. Brown EB, Campbell RB, Tsuzuki Y, Xu L, Carmeliet P, Fukumura D, Jain RK. In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat Med 2001, 7(7):864-868. 10.1038/89997, 11433354.
38. Odin C, Guilbert T, Alkilani A, Boryskina OP, Fleury V, Le Grand Y. Collagen and myosin characterization by orientation field second harmonic microscopy. Opt Express 2008, 16(20):16151-16165. 10.1364/OE.16.016151, 18825253.
39. Plotnikov SV, Millard AC, Campagnola PJ, Mohler WA. Characterization of the myosin-based source for second-harmonic generation from muscle sarcomeres. Biophys J 2006, 90(2):693-703. 10.1529/biophysj.105.071555, 1367074, 16258040.
40. Su PJ, Chen WL, Chen YF, Dong CY. Determination of collagen nanostructure from second-order susceptibility tensor analysis. Biophys J 2011, 100(8):2053-2062. 10.1016/j.bpj.2011.02.015, 3077698, 21504742.
41. Tiaho F, Recher G, Rouede D. Estimation of helical angles of myosin and collagen by second harmonic generation imaging microscopy. Opt Express 2007, 15(19):12286-12295. 10.1364/OE.15.012286, 19547597.
42. Lacomb R, Nadiarnykh O, Townsend SS, Campagnola PJ. Phase Matching considerations in Second Harmonic Generation from tissues: Effects on emission directionality, conversion efficiency and observed morphology. Opt Commun 2008, 281(7):1823-1832. 10.1016/j.optcom.2007.10.040, 2390911, 19343083.
43. Ghajar CM, Bissell MJ. Extracellular matrix control of mammary gland morphogenesis and tumorigenesis: insights from imaging. Histochem Cell Biol 2008, 130(6):1105-1118. 10.1007/s00418-008-0537-1, 2949356, 19009245.
44. Welter S, Jacobs J, Krbek T, Totsch M, Stamatis G. Pulmonary metastases of breast cancer. When is resection indicated. Eur J Cardiothorac Surg 2008, 34(6):1228-1234. 10.1016/j.ejcts.2008.07.063, 18824371.
45. Westermarck J, Kahari VM. Regulation of matrix metalloproteinase expression in tumor invasion. Faseb J 1999, 13(8):781-792.
46. Martin MD, Matrisian LM. The other side of MMPs: protective roles in tumor progression. Cancer Metastasis Rev 2007, 26(3-4):717-724.
47. Noel A, Gutierrez-Fernandez A, Sounni NE, Behrendt N, Maquoi E, Lund IK, Cal S, Hoyer-Hansen G, Lopez-Otin C. New and paradoxical roles of matrix metalloproteinases in the tumor microenvironment. Frontiers in pharmacology 2012, 3:140. 3398411, 22822400.
48. Zucker S, Cao J. Selective matrix metalloproteinase (MMP) inhibitors in cancer therapy: ready for prime time?. Cancer biology & therapy 2009, 8(24):2371-2373. 10.4161/cbt.8.24.10353, 24006487.
49. Overall CM, Kleifeld O. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 2006, 6(3):227-239. 10.1038/nrc1821, 16498445.
50. Bourboulia D, Stetler-Stevenson WG. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol 2010, 20(3):161-168. 10.1016/j.semcancer.2010.05.002, 2941566, 20470890.
51. Groblewska M, Siewko M, Mroczko B, Szmitkowski M. The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer. Folia Histochem Cytobiol 2012, 50(1):12-19.
52. Jiang Y, Goldberg ID, Shi YE. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 2002, 21(14):2245-2252. 10.1038/sj.onc.1205291, 11948407.
53. Hojilla CV, Mohammed FF, Khokha R. Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br J Cancer 2003, 89(10):1817-1821. 10.1038/sj.bjc.6601327, 2394437, 14612884.
54. Fukuda H, Mochizuki S, Abe H, Okano HJ, Hara-Miyauchi C, Okano H, Yamaguchi N, Nakayama M, D'Armiento J, Okada Y. Host-derived MMP-13 exhibits a protective role in lung metastasis of melanoma cells by local endostatin production. Br J Cancer 2011, 105(10):1615-1624. 10.1038/bjc.2011.431, 3242531, 22015555.
55. Tarin C, Gomez M, Calvo E, Lopez JA, Zaragoza C. Endothelial nitric oxide deficiency reduces MMP-13-mediated cleavage of ICAM-1 in vascular endothelium: a role in atherosclerosis. Arterioscler Thromb Vasc Biol 2009, 29(1):27-32. 10.1161/ATVBAHA.108.169623, 18988893.
56. Chang HJ, Yang MJ, Yang YH, Hou MF, Hsueh EJ, Lin SR. MMP13 is potentially a new tumor marker for breast cancer diagnosis. Oncol Rep 2009, 22(5):1119-1127.
57. Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 1996, 149(1):273-282. 1865221, 8686751.
58. Uria JA, Stahle-Backdahl M, Seiki M, Fueyo A, Lopez-Otin C. Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions. Cancer Res 1997, 57(21):4882-4888.
59. Pendas AM, Uria JA, Jimenez MG, Balbin M, Freije JP, Lopez-Otin C. An overview of collagenase-3 expression in malignant tumors and analysis of its potential value as a target in antitumor therapies. Clin Chim Acta 2000, 291(2):137-155. 10.1016/S0009-8981(99)00225-9, 10675720.
60. Saeidi N. On the control of collagen fibril organization and morphology. Mechanical Engineering Dissertations Paper 7 http://iris.lib.neu.edu/cgi/viewcontent.cgi?article=1006&context=mech_eng_diss 2009.
61. Bode M. Characterization of Type I and Type III collagens in human tissues hesis Dissertion, Oulu University Library, http://herkules.oulu.fi/isbn9514255534/isbn9514255534.pdf 2000.
62. Krane SM, Byrne MH, Lemaitre V, Henriet P, Jeffrey JJ, Witter JP, Liu X, Wu H, Jaenisch R, Eeckhout Y. Different collagenase gene products have different roles in degradation of type I collagen. J Biol Chem 1996, 271(45):28509-28515. 10.1074/jbc.271.45.28509, 8910479.
63. Silver FH, Freeman JW, Seehra GP. Collagen self-assembly and the development of tendon mechanical properties. J Biomech 2003, 36(10):1529-1553. 10.1016/S0021-9290(03)00135-0, 14499302.
64. Comper WD, Veis A. Characterization of nuclei in in vitro collagen fibril formation. Biopolymers 1977, 16(10):2133-2142. 10.1002/bip.1977.360161005, 334278.
65. Monfort J, Tardif G, Reboul P, Mineau F, Roughley P, Pelletier JP, Martel-Pelletier J. Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease-13: identification of a new biglycan cleavage site. Arthritis Res Ther 2006, 8(1):R26. 10.1186/ar1873, 1526547, 16507124.
66. Vogel KG, Paulsson M, Heinegard D. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 1984, 223(3):587-597. 1144341, 6439184.
67. Hakkinen L, Strassburger S, Kahari VM, Scott PG, Eichstetter I, Lozzo RV, Larjava H. A role for decorin in the structural organization of periodontal ligament. Lab Invest 2000, 80(12):1869-1880. 10.1038/labinvest.3780197, 11140699.
68. Zhang G, Ezura Y, Chervoneva I, Robinson PS, Beason DP, Carine ET, Soslowsky LJ, Iozzo RV, Birk DE. Decorin regulates assembly of collagen fibrils and acquisition of biomechanical properties during tendon development. J Cell Biochem 2006, 98(6):1436-1449. 10.1002/jcb.20776, 16518859.
69. Cameron GJ, Alberts IL, Laing JH, Wess TJ. Structure of type I and type III heterotypic collagen fibrils: an X-ray diffraction study. J Struct Biol 2002, 137(1-2):15-22.
70. Fleischmajer R, Perlish JS, Burgeson RE, Shaikh-Bahai F, Timpl R. Type I and type III collagen interactions during fibrillogenesis. Ann N Y Acad Sci 1990, 580:161-175. 10.1111/j.1749-6632.1990.tb17927.x, 2186689.
71. Romanic AM, Adachi E, Kadler KE, Hojima Y, Prockop DJ. Copolymerization of pNcollagen III and collagen I. pNcollagen III decreases the rate of incorporation of collagen I into fibrils, the amount of collagen I incorporated, and the diameter of the fibrils formed. J Biol Chem 1991, 266(19):12703-12709.